Frankfurt, Germany

Ralf Bierbaum

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Clariant Finance (Bvi) Limited. Active years: 2014.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralf Bierbaum: Innovator in Fatty Acid Amide Production

Introduction

Ralf Bierbaum is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of chemical engineering, particularly in the production of fatty acid amides. His innovative approach has led to the development of a unique method that enhances efficiency in this area.

Latest Patents

Ralf Bierbaum holds a patent for a continuous method for producing fatty acid amides. This invention involves the reaction of at least one fatty acid with an amine to form an ammonium salt, which is then converted into a fatty acid amide under microwave irradiation. The method is characterized by its orientation in the direction of microwave propagation, optimizing the reaction process.

Career Highlights

Ralf Bierbaum is associated with Clariant Finance (Bvi) Limited, where he applies his expertise in chemical processes. His work has been instrumental in advancing the production techniques within the company, showcasing his commitment to innovation in the chemical industry.

Collaborations

Throughout his career, Ralf has collaborated with esteemed colleagues such as Joerg Appel and Matthias Krull. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Ralf Bierbaum's contributions to the production of fatty acid amides exemplify the impact of innovative thinking in chemical engineering. His patent and collaborative efforts highlight the importance of continuous improvement in industrial processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…